Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism.
Further understanding of the causative link between plasma lipids and coronary heart disease will come from a deeper appreciation of the impact of lipoprotein heterogeneity on the processes of atherosclerosis and thrombosis. It is now widely appreciated that remnants of triglyceride-rich lipoproteins, IDL and specific LDL subfractions may have a role in atherogenesis disproportionate to the plasma concentrations of these species. Elucidation of the factors that control the distribution of subfractions within the spectrum of apolipoprotein B-containing lipoproteins is underway but far from complete. Important influences are the rate and nature of lipoproteins secreted from the liver, the extent of remodelling by lipid exchange and lipolysis in the circulation and the affinity of the various particles for cell surface receptors.
Packard
C J
CJ
Department of Pathological Biochemistry, Glasgow Royal Infirmary University NHS Trust, UK. chrispackard@compuserve.com
D001055:Apolipoproteins B / Q000378:metabolism*; D003327:Coronary Disease / Q000209:etiology* / Q000378:metabolism; D006801:Humans; D008077:Lipoproteins, LDL / Q000378:metabolism; D012307:Risk Factors; D014280:Triglycerides / Q000378:metabolism
D001055:Apolipoproteins B; D008077:Lipoproteins, LDL; D014280:Triglycerides